Nabriva Therapeutics (NBRVF) Q2 2020 Earnings

6AugExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
-0.33
-0.27
-0.2
-0.14

Details

Expected EPS
-0.16
Actual EPS
-0.14
Surprise EPS
0.02
Surprise Percent
+12.5%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.14 per share for Q2 2020.

0 Comments

Share your thoughts